Answers are grounded in this paper and cite their sources.
Lytic bone metastases are rare in prostate cancer. We here present 18 fluorine fluorodeoxyglucose ((18)F-FDG) positron emission tomography computed tomography (PET-CT) images of a 67-year-old male patient with lytic metastases from prostate cancer. Repeat (18)F-FDG PET-CT done 6 months later showed response to medical castration therapy. While the role of (18)F-FDG PET-CT for sclerotic bone metastases in prostate cancer remains controversial, it appears to be useful for detection and response assessment of lytic prostate cancer metastases.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: